Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK makes room for genetics revolution with £50 million plan

This article was originally published in Clinica

Executive Summary

The UK government has announced its "strategy for realising the potential of genetics in the NHS", backed by a £50m ($83m) three-year investment plan. The genetics white paper Our Inheritance, Our Future sets out the government's commitment to improve research and manufacturing facilities and widen access to the technology in primary care, as well as pledging to tighten the regulation of what remains a highly sensitive issue.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel